Wang et al. compared miRNA expression in normal human CD34+ cells with that in CML CD34+ cells, using human leukemia cell lines and CD34+ cells isolated from chronic phase CML patients who had not been treated with imatinib. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.